Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
2
×
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
johnson & johnson
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
opioid
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
What
drug
roundup
ahead
ambien
american
annual
approval
asco
attendees
attention
bio
biogen’s
biopharmaceutical
biotech
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
companies
convo
days
earlier
expanding
failures
focus
home
key
kicks
littered
meeting
nash
new
news
oncology
oncology’s
potential
Language
Current search:
opioid
×
biotech
×
" cancer immunotherapy "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
